189 related articles for article (PubMed ID: 22737248)
1. Multiorgan metastasis of human HER-2+ breast cancer in Rag2-/-;Il2rg-/- mice and treatment with PI3K inhibitor.
Nanni P; Nicoletti G; Palladini A; Croci S; Murgo A; Ianzano ML; Grosso V; Stivani V; Antognoli A; Lamolinara A; Landuzzi L; di Tomaso E; Iezzi M; De Giovanni C; Lollini PL
PLoS One; 2012; 7(6):e39626. PubMed ID: 22737248
[TBL] [Abstract][Full Text] [Related]
2. High metastatic efficiency of human sarcoma cells in Rag2/gammac double knockout mice provides a powerful test system for antimetastatic targeted therapy.
Nanni P; Nicoletti G; Landuzzi L; Croci S; Murgo A; Palladini A; Antognoli A; Ianzano ML; Stivani V; Grosso V; Maira SM; García-Echeverría C; Scotlandi K; De Giovanni C; Lollini PL
Eur J Cancer; 2010 Feb; 46(3):659-68. PubMed ID: 20031388
[TBL] [Abstract][Full Text] [Related]
3. Glomerular common gamma chain confers B- and T-cell-independent protection against glomerulonephritis.
Luque Y; Cathelin D; Vandermeersch S; Xu X; Sohier J; Placier S; Xu-Dubois YC; Louis K; Hertig A; Bories JC; Vasseur F; Campagne F; Di Santo JP; Vosshenrich C; Rondeau E; Mesnard L
Kidney Int; 2017 May; 91(5):1146-1158. PubMed ID: 28111009
[TBL] [Abstract][Full Text] [Related]
4. Preclinical therapy of disseminated HER-2⁺ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus.
Nanni P; Gatta V; Menotti L; De Giovanni C; Ianzano M; Palladini A; Grosso V; Dall'ora M; Croci S; Nicoletti G; Landuzzi L; Iezzi M; Campadelli-Fiume G; Lollini PL
PLoS Pathog; 2013 Jan; 9(1):e1003155. PubMed ID: 23382683
[TBL] [Abstract][Full Text] [Related]
5. An immunotolerant HER-2/neu transgenic mouse model of metastatic breast cancer.
Song H; Shahverdi K; Huso DL; Wang Y; Fox JJ; Hobbs RF; Gimi B; Gabrielson KL; Pomper MG; Tsui BM; Bhujwalla Z; Reilly RT; Sgouros G
Clin Cancer Res; 2008 Oct; 14(19):6116-24. PubMed ID: 18829490
[TBL] [Abstract][Full Text] [Related]
6. Increased and prolonged human norovirus infection in RAG2/IL2RG deficient gnotobiotic pigs with severe combined immunodeficiency.
Lei S; Ryu J; Wen K; Twitchell E; Bui T; Ramesh A; Weiss M; Li G; Samuel H; Clark-Deener S; Jiang X; Lee K; Yuan L
Sci Rep; 2016 Apr; 6():25222. PubMed ID: 27118081
[TBL] [Abstract][Full Text] [Related]
7. Biological Characteristics of Severe Combined Immunodeficient Mice Produced by CRISPR/Cas9-Mediated
Zhao Y; Liu P; Xin Z; Shi C; Bai Y; Sun X; Zhao Y; Wang X; Liu L; Zhao X; Chen Z; Zhang H
Front Genet; 2019; 10():401. PubMed ID: 31134127
[TBL] [Abstract][Full Text] [Related]
8. The SRG rat, a Sprague-Dawley Rag2/Il2rg double-knockout validated for human tumor oncology studies.
Noto FK; Sangodkar J; Adedeji BT; Moody S; McClain CB; Tong M; Ostertag E; Crawford J; Gao X; Hurst L; O'Connor CM; Hanson EN; Izadmehr S; Tohmé R; Narla J; LeSueur K; Bhattacharya K; Rupani A; Tayeh MK; Innis JW; Galsky MD; Evers BM; DiFeo A; Narla G; Jamling TY
PLoS One; 2020; 15(10):e0240169. PubMed ID: 33027304
[TBL] [Abstract][Full Text] [Related]
9. IL2RG-deficient minipigs generated via CRISPR/Cas9 technology support the growth of human melanoma-derived tumours.
Ren J; Yu D; Fu R; An P; Sun R; Wang Z; Guo R; Li H; Zhang Y; Li Z; Yang YG; Li W; Hai T; Hu Z
Cell Prolif; 2020 Oct; 53(10):e12863. PubMed ID: 32871045
[TBL] [Abstract][Full Text] [Related]
10. An improved model to study tumor cell autonomous metastasis programs using MTLn3 cells and the Rag2(-/-) gammac (-/-) mouse.
Le Dévédec SE; van Roosmalen W; Maria N; Grimbergen M; Pont C; Lalai R; van de Water B
Clin Exp Metastasis; 2009; 26(7):673-84. PubMed ID: 19466569
[TBL] [Abstract][Full Text] [Related]
11. Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice.
Azuma H; Paulk N; Ranade A; Dorrell C; Al-Dhalimy M; Ellis E; Strom S; Kay MA; Finegold M; Grompe M
Nat Biotechnol; 2007 Aug; 25(8):903-10. PubMed ID: 17664939
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of NVP-BKM120--a selective pan class I PI3 kinase inhibitor showed differential forms of cell death based on p53 status of glioma cells.
Koul D; Fu J; Shen R; LaFortune TA; Wang S; Tiao N; Kim YW; Liu JL; Ramnarian D; Yuan Y; Garcia-Echevrria C; Maira SM; Yung WK
Clin Cancer Res; 2012 Jan; 18(1):184-95. PubMed ID: 22065080
[TBL] [Abstract][Full Text] [Related]
13. Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain.
Palmieri D; Bronder JL; Herring JM; Yoneda T; Weil RJ; Stark AM; Kurek R; Vega-Valle E; Feigenbaum L; Halverson D; Vortmeyer AO; Steinberg SM; Aldape K; Steeg PS
Cancer Res; 2007 May; 67(9):4190-8. PubMed ID: 17483330
[TBL] [Abstract][Full Text] [Related]
14. In Vivo Selection of Intermediately- and Highly-Malignant Variants of Triple-negative Breast Cancer in Orthotopic Nude Mouse Models.
Yano S; Takehara K; Kishimoto H; Tazawa H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
Anticancer Res; 2016 Dec; 36(12):6273-6277. PubMed ID: 27919946
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice.
Kim LS; Huang S; Lu W; Lev DC; Price JE
Clin Exp Metastasis; 2004; 21(2):107-18. PubMed ID: 15168728
[TBL] [Abstract][Full Text] [Related]
16. The PFP/RAG2 double-knockout mouse in metastasis research: small-cell lung cancer and prostate cancer.
Müller I; Ullrich S
Methods Mol Biol; 2014; 1070():191-201. PubMed ID: 24092441
[TBL] [Abstract][Full Text] [Related]
17. Targeting the Transforming Growth Factor-beta pathway inhibits human basal-like breast cancer metastasis.
Ganapathy V; Ge R; Grazioli A; Xie W; Banach-Petrosky W; Kang Y; Lonning S; McPherson J; Yingling JM; Biswas S; Mundy GR; Reiss M
Mol Cancer; 2010 May; 9():122. PubMed ID: 20504320
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
Tan M; Yao J; Yu D
Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293
[TBL] [Abstract][Full Text] [Related]
19. The combination of NVP-BKM120 with trastuzumab or RAD001 synergistically inhibits the growth of breast cancer stem cells in vivo.
Yu F; Zhao J; Hu Y; Zhou Y; Guo R; Bai J; Zhang S; Zhang H; Zhang J
Oncol Rep; 2016 Jul; 36(1):356-64. PubMed ID: 27175939
[TBL] [Abstract][Full Text] [Related]
20. Uterine natural killer cells pace early development of mouse decidua basalis.
Hofmann AP; Gerber SA; Croy BA
Mol Hum Reprod; 2014 Jan; 20(1):66-76. PubMed ID: 24000237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
